Nawaloka Hospitals PLC (COSE:NHL.N0000)
0.00
0.00 (0.00%)
Price not available due to exchange restrictions
Nawaloka Hospitals Ratios and Metrics
Market cap in millions LKR. Fiscal year is April - March.
Millions LKR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 19,028 | 7,470 | 5,497 | 8,034 | 9,162 | 6,907 | |
Market Cap Growth | 104.55% | 35.90% | -31.58% | -12.31% | 32.65% | 68.97% |
Enterprise Value | 26,689 | 15,018 | 12,325 | 16,308 | 18,184 | 17,271 |
Last Close Price | 13.50 | 5.30 | 3.90 | 5.70 | 6.50 | 4.90 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
PE Ratio | 19.02 | 132.50 | - | - | - | 13.78 |
PS Ratio | 1.51 | 0.68 | 0.53 | 0.86 | 0.60 | 0.58 |
PB Ratio | 3.13 | 1.52 | 1.20 | 1.63 | 1.37 | 1.69 |
P/TBV Ratio | 3.13 | 1.52 | 1.20 | 1.63 | 1.37 | 1.69 |
P/FCF Ratio | - | 9.42 | 2.69 | 2.92 | 7.28 | - |
P/OCF Ratio | 12.82 | 6.59 | 2.59 | 2.79 | 3.86 | 13.18 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
EV/Sales Ratio | 2.11 | 1.36 | 1.19 | 1.75 | 1.19 | 1.46 |
EV/EBITDA Ratio | 9.65 | 8.32 | 6.66 | 21.60 | 6.63 | 7.42 |
EV/EBIT Ratio | 15.06 | 14.97 | 12.03 | - | 9.50 | 11.51 |
EV/FCF Ratio | - | 18.94 | 6.02 | 5.93 | 14.44 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Debt / Equity Ratio | 1.40 | 1.58 | 1.64 | 1.65 | 1.45 | 2.86 |
Debt / EBITDA Ratio | 3.34 | 4.26 | 3.98 | 9.01 | 3.31 | 4.71 |
Debt / FCF Ratio | - | 9.82 | 3.67 | 2.96 | 7.67 | - |
Net Debt / Equity Ratio | 1.29 | 1.46 | 1.53 | 1.60 | 1.33 | 2.57 |
Net Debt / EBITDA Ratio | 3.23 | 3.97 | 3.80 | 10.40 | 3.23 | 4.53 |
Net Debt / FCF Ratio | -17.04 | 9.04 | 3.44 | 2.85 | 7.03 | -161.27 |
Asset Turnover | 0.62 | 0.57 | 0.55 | 0.48 | 0.79 | 0.65 |
Inventory Turnover | 11.89 | 12.42 | 13.61 | 10.45 | 15.07 | 13.85 |
Quick Ratio | 0.61 | 0.25 | 0.19 | 0.18 | 0.66 | 0.48 |
Current Ratio | 0.71 | 0.32 | 0.26 | 0.24 | 0.80 | 0.57 |
Return on Equity (ROE) | 18.74% | 1.19% | -6.41% | -42.02% | -1.79% | 13.31% |
Return on Assets (ROA) | 4.72% | 3.24% | 3.40% | -0.24% | 6.16% | 5.15% |
Return on Invested Capital (ROIC) | 7.77% | 1.42% | 8.40% | -0.52% | -2.69% | 10.55% |
Return on Capital Employed (ROCE) | 9.10% | 9.50% | 9.90% | -0.60% | 13.00% | 13.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 6, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Earnings Yield | 5.35% | 0.76% | -5.54% | -30.35% | -1.05% | 7.26% |
FCF Yield | -2.41% | 10.61% | 37.24% | 34.26% | 13.74% | -0.95% |
Payout Ratio | - | - | - | - | - | 0.00% |